Go Your Own Way: Vector Laboratories Completes $124 Million Buyout and Initiates Acquisition Strategy
Genetic Engineering & Biotechnology News. The new funding, backed by private equity firm Thompson Street Capital Partners, enables Vector Laboratories to embark upon an acquisition strategy while accelerating the commercialization of innovative labeling and detection technologies for immunohistochemistry, immunofluorescence, glycobiology, and bioconjugation. Read article

